Conavi Medical Corp.
CNVIF
$0.4571
$0.094225.96%
| Weiss Ratings | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.93% | |||
| 30-Day Total Return | -26.27% | |||
| 60-Day Total Return | 2.19% | |||
| 90-Day Total Return | -44.26% | |||
| Year to Date Total Return | 3.89% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -63.71% | |||
| 52-Week Low % Change | 51,742.86% | |||
| Price | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.00 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Nov 21, 2024 | |||
| 52-Week High Price (Date) | Oct 15, 2024 | |||
| Valuation | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 19.92M | |||
| Enterprise Value | 89.98M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -3.46 | |||
| Earnings Per Share Growth | 117.36% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.47 | |||
| Price/Book (Q) | -0.03 | |||
| Enterprise Value/Revenue (TTM) | 139.34 | |||
| Price | $0.46 | |||
| Enterprise Value/EBITDA (TTM) | -8.20 | |||
| Enterprise Value/EBIT | -8.03 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.17M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | -- | |||
| Address | 293 Lesmill Road Toronto, ON M3B 2V1 | |||
| Website | conavi.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -- | |||
| Return on Equity | -- | |||
| Income Statement | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | $0.11 | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -- | |||
| Net Income (TTM) | -- | |||
| Net Income Avl. to Common (TTM) | -- | |||
| Total Revenue Growth (Q YOY) | -75.89% | |||
| Earnings Growth (Q YOY) | -124.18% | |||
| EPS Diluted (TTM) | -- | |||
| EPS Diluted Growth (Q YOY) | -123.82% | |||
| Balance Sheet | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 322.70K | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 2.61M | |||
| Total Preferred Equity (Q) | 13.63 | |||
| Total Equity (Q) | -63.54M | |||
| Current Ratio (Q) | 0.125 | |||
| Book Value Per Share (Q) | -$12.52 | |||
| Total Assets (Q) | 6.34M | |||
| Total Current Liabilities (Q) | 20.87M | |||
| Total Debt (Q) | 61.57M | |||
| Total Liabilities (Q) | 69.87M | |||
| Total Common Equity (Q) | -77.16M | |||
| Cash Flow | CNVIF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -- | |||
| Net Change in Cash (TTM) | -- | |||
| Levered Free Cash Flow (TTM) | -- | |||
| Cash from Operations (TTM) | -- | |||
